Close Menu

NEW YORK – Diagnostic firm SpeeDx announced Tuesday a partnership with Roche to expand global access to the firm's infectious disease and antibiotic resistance tests and technology.

Under the non-exclusive agreement, Roche will have access to SpeeDx's existing tests and technology, expanding patient access to diagnostic products, including new ones, for the management of antibiotic resistance in sexually transmitted infections, the firm said in a statement.

Financial and other terms of the deal were not disclosed. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.